Aspire Biopharma Holdings (ASBP) Stock Statistics & Valuation Metrics

Aspire Biopharma Holdings has a market cap or net worth of $5.28M. The enterprise value is $4.02M.

Aspire Biopharma Holdings has 5,024,124 shares outstanding. The number of shares has decreased by -2.65% in one year.

Aspire Biopharma Holdings’s return on equity (ROE) is 3.84 and return on invested capital (ROIC) is 395.26%.

The current PE Ratio of Aspire Biopharma Holdings is ―. Aspire Biopharma Holdings’s PEG ratio is -0.00008.

In the last 12 months, Aspire Biopharma Holdings had revenue of 6.20K and earned -24.48M in profits. Earnings per share was -16.38.

In the last 12 months, operating cash flow was -4.92M and capital expenditures 0.00, giving a free cash flow of -4.92M billion.

Aspire Biopharma Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Aspire Biopharma Holdings upcoming earnings date is ―, ―.

Aspire Biopharma Holdings as a current ratio of 0.17, with Debt / Equity ratio of -21.72%

In the past 12 months, Aspire Biopharma Holdings has paid 0.00 in taxes.

Aspire Biopharma Holdings EV to EBITDA ratio is -0.43, with an EV/FCF ratio of -1.68.

Aspire Biopharma Holdings has $1.00M in cash and marketable securities with $1.38M in debt, giving a net cash position of -$380.87K billion.

Gross margin is -1.87%, with operating margin of -312016.95%, and net profit margin of -394725.06%.

The average price target for Aspire Biopharma Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―